Thoracic Anesthesia for the Geriatric Patient


Introduction

Among the geriatric population, there is great variability in physiologic condition from person to person. Because of this variability, the patient’s preoperative functional status, comorbidities, and tumor stage may influence surgical outcomes more than chronologic age alone. However, even an otherwise healthy older person will exhibit limited physiologic reserve because of the normal process of aging. Optimal management of these patients in the perioperative period will necessitate an understanding of changes in physiologic reserve and consideration of comorbid conditions and overall health status. Chronic obstructive pulmonary disease (COPD) and congestive heart failure in particular have implications for postoperative morbidity and mortality. Patient quality of life, overall life expectancy, and functional status must also be considered.

Various studies involving preoperative assessment aim to elucidate risk factors and implement resources to optimize overall patient health and physiologic condition, and thus decrease morbidity and mortality. Minimally invasive surgical techniques, extent of surgical resection, and anesthetic considerations may all play roles in achieving satisfactory outcomes in this population.

Demographics

It is predicted that by the year 2030, there will be more than 70 million United States citizens over the age of 65 years. Adults 85 years old or older are the fastest growing age group in the United States. By 2060, the number of people aged 85 years and older is expected to nearly triple from 6.4 million in 2016 to 19 million.

Cancer is the second leading cause of death in the United States, and the probability of developing cancer increases with age. Among people age 60 to 79 years, it is the leading cause of death. The incidence of cancer is 9.8 times greater among people older than 65 years than those younger than 65 years. According to the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program, 56% of all new cancer diagnoses were among patients older than 65 years. Almost two-thirds of cancer survivors are aged 65 years or older. People older than 85 years make up 2% of the population, but 8% of all new cancer diagnoses. It is estimated that there were 228,150 new diagnoses of cancer of the lung or bronchus, and 142,670 deaths from these cancers in 2019. Lung cancer is the most common cause of cancer death, compromising 25% of all cancer deaths. It is the second most common cancer diagnosis for both men and women. The median age of lung cancer patients presenting for surgery is greater than 70 years.

The expanding geriatric population, with its increased risk of cancer compared with younger patients, will lead to an increase in elderly patients presenting for thoracic surgery. Thoracic anesthesiologists must be adept at caring for patients who may have a wide range of chronic conditions, as well as suffer from expected age-related physiologic changes.

Physiology of Aging

Elderly patients may exhibit a limited ability to respond to the stress of illness or major surgery because of the natural decline of maximal physiologic reserves. Manifestations of pathology may be blunted, and a geriatric patient may have symptoms that are atypical, diminished, or misdiagnosed as simply because of “old age.” The incidence of comorbidities is increased in this patient population, especially cardiovascular disease and pulmonary disease. These comorbidities superimposed on normal senescence can make management of elderly patients more complex.

Cardiovascular Changes

Interrelated molecular and structural changes occur within the myocardium, aorta, and cardiac conduction system ( Table 38.1 ). The breakdown of elastin and increased collagen deposition and cross-linking cause vascular stiffness, which increases impedance and peripheral vascular resistance. The aorta becomes more dilated, exhibiting decreased compliance associated with higher wall tension, as large elastic arteries become stiffer with an increase in pulse wave velocity and pulse pressure. This in turn is associated with an increase in left ventricular (LV) afterload with LV dilatation or reduced ejection fraction. Coronary arteries may develop plaques and calcified lesions, as well as fixed stenoses.

Table38.1
Age-Related Cardiovascular Changes
Cardiac Progressive cardiomyocyte hypertrophy
Gradual development of cardiac fibrosis
Increased collagen deposition and altered cross-linking
Increased fatty infiltration and extracellular matrix degradation capacity
Decreased myocardial reserve capacity
Decreased left ventricular (LV) function
Increased LV mass secondary to increased wall thickness and volumes
Prolonged systolic contraction and diastolic relaxation
Increased risk of conduction defectsDecreased heart rate variability
Increased stroke work
Increased dependence on preload and atrial kick
Decreased autophagy
Accumulation of misfolded proteins and dysfunctional mitochondria
Vascular Increased afterload
Increased peripheral vascular resistance
Increased incidence of coronary artery disease, plaques, calcification, and fixed stenosis
Impaired vasodilation
Decreased arterial elasticity
Aortic dilation and increased pulse wave velocity
Aortic thickening with decreased compliance and higher wall tension
Reflex regulation Decreased sympathetic signaling
Baroreceptor impairment
Decreased chronotropic and inotropic response to catecholamines
Decreased maximal cardiac output and heart rate
Diminished autonomic control of peripheral vascular resistance
Modified from Castillo MD, Port J, Heerdt PM. Thoracic surgery in the elderly. In: Slinger P, ed. Principles and Practice of Anesthesia for Thoracic Surgery . 2nd ed. Switzerland: Springer; 2019; Meschiari CA, Ero OK, Pan H, Finkel T, Lindsey ML. The impact of aging on cardiac extracellular matrix. Geroscience . 2017;39(1):7–18; Shirakabe A, Ikeda Y, Sciaretta S, Zablocki DK, Sadoshima J. Aging and autophagy in the heart. Circ Res . 2016;118(10):1563–1576.

Progressive myocyte hypertrophy, myocardial fibrosis, inflammation, valvular sclerosis, and calcification lead to increased LV mass over time and decreased compliance. Subcellular changes in myocyte calcium cycling occur that allow the ventricle to maintain tension against increased afterload, which can be helpful in some situations but maladaptive under other conditions, such as in the setting of tachycardia. In such a situation, delayed relaxation can impede chamber filling. Over time, there is an accumulation of misfolded proteins and dysfunctional mitochondria, as well as decreased in dysfunctional cell components removal by autophagy. Cardiac aging is characterized by the presence of hypertrophy, fibrosis, and accumulation of misfolded proteins and dysfunctional mitochondria. Autophagy may play an important role in combating the adverse effects of aging in the heart. Autophagy is a lysosome-dependent bulk degradation mechanism that is essential for intracellular protein and organelle quality control. Autophagic flux is generally decreased in aging hearts, with loss of function that develops exacerbated cardiac dysfunction that is accompanied by accumulation of misfolded proteins and dysfunctional organelles. Stimulation of autophagy generally improves cardiac function by removing accumulated misfolded proteins, dysfunctional mitochondria, and damaged deoxyribonucleic acid, thereby improving the overall cellular environment and alleviating aging-associated pathology in the heart. Increases in fatty infiltration, fibrosis, and amyloid content can result from altered collagen cross-linking that can increase the risk of conduction defects. Hypertrophic myocytes demand more energy and oxygen. As a result, cardiac performance may be maintained under normal circumstances, however, the diminished cardiac reserve may become apparent when the patient’s heart is subjected to increased workload or stressors.

Homeostatic reflexes are dampened, which increases the impact of the age-related decline in cardiovascular reserve. Typical changes include decreased baroreceptor sensitivity, myocardial response to catecholamines, and autonomic control of peripheral vascular resistance. Maximal heart rate and cardiac output decrease as well.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here